Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Editorial · May 2015 Conference abstract · 10 Jun 2013 Inference after a multistage single-arm trial incorporating multiple endpoints
toxicity into the sample size calculations. Often, the trial is designed with the primary endpoint of interest and it is augmented with monitoring rules for safety such as Continuous Toxicity ... Simon 2-Stage design…
Conference abstract · 13 Nov 2017 Unbiased estimation after phase II clinical trials involving multiple endpoints
The single arm, two-stage clinical trial design is a popular methodology
Conference abstract · 27 Jul 2018 Comparison of three sample size estimation methods for non-inferiority vaccine trials with multiple continuous co-primary endpoints
method, the “Incrementing method” and the Bonferroni correction method when there are multiple continuous co-primary endpoints. The parameters are set according to the actual situation of combination vaccines
Conference abstract · 18 Mar 2019 In vitro safety, efficacy and mechanism of action of an isotonic seawater solution for nasal hygiene
mass-spectrometry and chromatography. Preclinical efficacy and mechanism of action have been assessed by multiple endpoints to obtain robust body of evidences: mucociliary clearance (MCC), wound repair, decongestant…
Conference abstract Evaluation of ingredients for topical specific applications: an in vitro tolerance approach
well-tolerated doses of emulsifiers and thickeners, pillars of topical pharmaceutical formulations. The multiple endpoints analysis (MEA) designed for injured epidermis model enriches basic irritation information with…
Conference abstract · 4 Oct 2018 Modelling mutational signatures of environmental carcinogens in cultured human cells
Dertinger S D, et al. (2018) Benchmark dose analyses of multiple genetic toxicity endpoints permit robust, cross-tissue comparisons of MutaMouse responses to orally delivered benzo[a]pyrene. Arch. Toxicol
Research article · 2016 Challenges and Innovations in Phase I Dose-Finding Designs for Molecularly Targeted Agents and Cancer Immunotherapies
prolonged treatment cycles often involved. Various phase I designs using toxicity and efficacy endpoints from multiple treatment cycles have been developed for these new treatment agents. Here, we will review
Research article · 2017 Effect of Fish oil Vs. Resolvin D1, E1, Methyl Esters of Resolvins D1 or D2 on Diabetic Peripheral Neuropathy
weight resolvins D1, E1 or methyl esters of resolvins D1 or D2. Afterwards, multiple neurological endpoints were examined.Results: Menhaden oil or resolvins did not improve hyperglycemia. Untreated diabetic mice were
Research article · 4 Oct 2018 Hyperdiploidy is a Positive Prognostic Factor for Progression-Free Survival in Multiple Myeloma with High and Intermediate Risk Cytogenetics
Saudi Arabia and detected an array of endpoints including riskassociated cytogenetic endpoints. We analyzed data from 48 Multiple Myeloma cases at the King Fahad specialist hospital in Saudi Arabia ... array of…
Short communication · 22 May 2021 Modelling mutational signatures of environmental carcinogens in cultured human cells
Dertinger S D, et al. (2018) Benchmark dose analyses of multiple genetic toxicity endpoints permit robust, cross-tissue comparisons of MutaMouse responses to orally delivered benzo[a]pyrene. Arch. Toxicol
Research article · 14 Jul 2016 HbA1c LEVEL CORRELATION AS A PREDICTOR OF CORONARY ARTERY DISEASE AND ITS SEVERITY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
acute myocardial infarction) and the number of coronary artery stenoses (single, and multiple vessels). Primary endpoint was to evaluate relationship between baseline HbA1c value and CAD severity. RESULTS Consistent
Article · 22 Jan 2026 Cellular, Molecular, and Pharmacological Characterization of a House Dust Mites (HDM)-Induced Murine Model of Dermatitis
than BALB/c mice as evidenced by greater changes in in-life endpoints (clinical scores, ear thickness, scratching bouts, and TEWL), histological markers (overall inflammation, acanthosis, and parakeratosis), and tissue…
Conference abstract · 25 Aug 2015 Diet, Exercise, and Endothelial Function in Obese Adolescents
influence of a multicomponent treatment program on micro vascular function in obese adolescents. Additional endpoints were a reduced BMI SD-score, improved exercise capacity and an increase in Endothelial Progenitor…
Conference abstract · 22 Aug 2016 Retrospective analysis of clinical pharmacist medication counseling to improve patient medication compliance and patient retention
patient retention and can have a beneficial impact on achieving primary endpoints and health outcomes. Statistical analysis of multiple clinical trials involving a chronic disease medication (diabetes) with clinical…
Conference abstract · 19 Feb 2018 Impact of Socioeconomic Deprivation on Heart Failure Management and Clinical Outcomes
failure(HF) from the most deprived and least deprived tertile of Scottish Index of Multiple Deprivation (SIMD) (1 – 3 – most deprived and 7 - 9 – least deprived). Between the two groups ... months follow-up demonstrates…
Conference abstract · 2017 Importance of walking speed assessment as an indicator of functional improvement in adults with spastic hemiparesis after repeated administrations of abobotulinum toxin A
with chronic hemiparesis (NCT01249404), followed by an open-label multiple-cycle extension study (NCT01251367). Muscle tone was the primary endpoint; unassisted Comfortable Barefoot Walking Speed (CBWS) was the…
Article · 2015 Outcomes of a Switch to Fingolimod to Treat Relapsing Multiple Sclerosis: A Patient Subgroup Post Hoc Analysis
Secondary endpoints were changes in scores for the TSQM Effectiveness, Side Effects and Convenience subscales, Beck Depression Inventory-II, Fatigue Severity Scale, Patient-Reported Outcome Indices for Multiple…
Conference abstract · 23 Sep 2013 Trial designs for biosimilars development
trial designer, including choice of endpoints, time on study, fixed design or adaptive (e.g., group sequential), single dose or multiple dose. For each phase, we discuss several of the more
Conference abstract · 4 Aug 2016 Cataract – The dawning of a new age in its prevention and treatment
major cause of blindness. There are multiple mechanism(s) and it is also emerging that some cataracts are staging points rather than endpoints as revealed recently by the effects
Research article · 15 Jan 2018 Increased All-cause Mortality, Total Cardiovascular Disease and Morbidity in Hospitalized Elderly Patients with Orthostatic Hypotension.
factors for orthostatic hypotension are age, multiple medications, smoking, low BMI, hypertension and diabetes. Most of the knowledge on orthostatic hypotension and cardiovascular endpoints and mortality comes from…
Editorial · 2011 The Role of Tissue Microenvironment in Breast Cancer Development and Importance of its Behavioral Profiling for Individually Tailored Therapy
Invasive breast cancer is the endpoint of complicated evolutionary process starting in TDLU of mammary gland. It is the network of multiple-step mechanism including cell proliferation, differentiation, atypical…
Conference abstract · 2019 Efficacy, durability and safety of ampreloxetine, a norepinephrine reuptake inhibitor, given once daily to treat neurogenic orthostatic hypotension (nOH) in subjects with primary autonomic failure
treatment of symptomatic nOH. Methods: This was a phase 2 multicenter, single and multiple-dose study of subjects with nOH. After a single dose escalation phase, responders were enrolled ... daily for up to 20 weeks…
Short communication · 23 Sep 2022 Teens and millennials with hyperglycaemia and the implications of tracking on glycaemic control.
weeks was the primary endpoint. There were 20 secondary outcomes, which included additional HbA1c outcomes, CGM glucose measures, and patient-reported outcomes with multiple comparisons adjusted
Research article · 18 Dec 2020 No Clear Benefit to the use of Corticosteroid as Treatment in Adult Patients with Coronavirus Disease 2019: A Retrospective Cohort Study
clinical outcomes. The primary endpoint was defined as either mortality or intensive care unit (ICU) admission. Known adverse prognostic factors were used as covariates in multiple logistic regressions to adjust

